![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Govi-Verlag
ISSN: 2195-2175
Source: PHARMAKON, Vol.2, Iss.6, 2014-11, pp. : 388-394
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Neurodegeneration and Neuroprotection in Multiple Sclerosis
Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 1, 2014-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 3, 2008-06 ,pp. :